Bir sonraki

Zealand's obesity drug shouldn't disrupt Novo Nordisk-Eli Lilly leadership: Mizuho's

26/02/24
CNBC Television

Jared Holz, Mizuho, joins 'Fast Money' to talk obesity drugmakers after a new study out of Zealand Pharma analyzed the impact of GLP-1s on liver disease.

Daha fazla göster

 0 Yorumlar sort   Göre sırala


Bir sonraki